Gut bacteria + AI may outperform standard colon cancer screening

NCT ID NCT06174233

Recruiting now Diagnosis Sponsor: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 36 times

Summary

This study aims to see if analyzing the bacteria in a person's stool using artificial intelligence can better predict colorectal cancer risk than the standard stool test (FIT). Researchers will collect stool samples from 2,500 people aged 50-75 who are scheduled for a colonoscopy. They will compare the accuracy of the new AI-based test against the standard test to see which one better identifies who truly has cancer or precancerous growths.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hopital Avicenne, Centre de Recherche sur Volontaire
RECRUITING

Bobigny, 93000, France

Contact Email: •••••@•••••

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PATIENTS AGED 50-75 AND REQUIRING COLONOSCOPY PATIENTS AGED 50-75 AND REQUIRING COLONOSCOPY

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

COLORECTAL CANCER